March 12 is World Alloimmunization and HDFN Awareness Day! We are so excited to have a day dedicated to spreading awareness about alloimmunization and HDFN and celebrating our incredible community. On this day, we celebrate the strength and resiliency of families who have experienced this rare, complicated disease, and the medical communities who support them…. Read More »

SMFM 2025 exceeded our expectations and left us feeling hopeful and inspired. It was a pleasure to reconnect with some of the dedicated providers shaping the future of maternal-fetal medicine, including Dr. Juan Gonzalez (UCSF) and Dr. Saul Snowise (Midwest Fetal Care Center) from our Medical Advisory Board, as well as Dr. Leonardo Pereira (OHSU),… Read More »

Returning to Kenya: Expanding Hope and Advancing Care in 2025 In January 2025, The Allo Hope Foundation returned to Kenya, deepening our commitment to improving care for alloimmunized mothers and babies affected by Hemolytic Disease of the Fetus and Newborn (HDFN). Partnering with our incredible AHF Africa Ambassador, Rose Murage, and an ever-growing network of… Read More »

On November 20, 2024, we joined the THOR Network Foundation, The Department of Defense and experts in trauma, transfusion medicine, maternal fetal medicine, and neonatology for a groundbreaking conference:  Emergency Transfusion in Females with Childbearing Potential: Mitigating the Risks of Hemolytic Disease of the Fetus and Newborn. Patients, providers and advocates worked across disciplines to… Read More »

We were honored to exhibit and present at the 2024 THOR- Trauma Hemostasis and Oxygenation Research Network Conference in Miami. Our Director of Research, Molly Sherwood, did a fantastic job sharing vital HDFN information, patient experiences, research outcomes and details about our upcoming Consensus Guidelines Conference through her presentation. Thank you to the THOR network… Read More »

We are excited to announce the launch of Season 3 of the Allo Podcast on November 5! Whether you’re a healthcare professional or a patient, there is something for you. Stay tuned for episodes covering breakthroughs in HDFN care, interviews with HDFN experts, global treatment approaches, and powerful, real life survival stories. We can’t wait… Read More »

Molly Sherwood, AHF’s Director of Research, presented on emerging treatments for HDFN at the 2024 Association for Advancements of Blood and Biotherapies (AABB) meeting in Houston, Texas. Molly discussed patient perspectives on the treatability of HDFN and new clinical trial results on nipocalimab for early onset severe HDFN and darbepoetin alfa for the reduction in… Read More »

The Allo Hope Foundation was officially founded five years ago and we are celebrating all of the accomplishments, relationships, advancements, support resources, community and love that has grown since then. Thank you for joining us in our fight against alloimmunization and HDFN. We love this community, we love your babies and we can’t wait to… Read More »

We had the incredible honor of participating in the WIRhE (Worldwide Initiative for Rh Disease Eradication) international, multidisciplinary board meeting in Amsterdam on July 1 and 2, 2024. We were surrounded by professionals passionate about helping the most vulnerable populations prevent and treat Alloimmunization and HDFN. Key conclusions from the meeting highlight that Rh disease… Read More »

Our Director of Development, Katie Shanahan, had the incredible opportunity of presenting the patient perspective at ISBT (International Society of Blood Transfusion) in Barcelona and what can be done to improve outcomes for alloimmunized women. Thank you to Dr. Phil Spinella for the opportunity and for amplifying the patient voice in the transfusion community!